Skip to content

Functional Strength Training and Kinesiotaping, With and Without Proprioceptive Neuromuscular Facilitation in Fibular (Peroneal) Neuropathy

"Functional Strength Training and Kinesiotaping With and Without Proprioceptive Neuromuscular Facilitation Technique in Fibular (Peroneal) Neuropathy"

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07191301
Enrollment
48
Registered
2025-09-24
Start date
2025-08-10
Completion date
2025-12-30
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peroneal Neuropathy

Brief summary

Fibular neuropathy frequently manifests as foot drop, muscle weakness, altered gait, and sensory loss, all of which severely reduce mobility and quality of life. There is still uncertainty regarding the efficacy of kinesio taping (KT), proprioceptive neuromuscular facilitation (PNF), and functional strength training (FST) in combination. Although PNF improves neuromuscular coordination, KT provides proprioceptive input, and FST increases strength and mobility, there are no set treatment guidelines and little research has compared these modalities. In order to contribute to evidence-based rehabilitation techniques for people with fibular neuropathy, this study attempts to assess whether adding PNF to FST and KT improves functional outcomes compared to FST and KT alone.

Interventions

BEHAVIORALFunctional Strength Training, Kinesio Taping, and Proprioceptive Neuromuscular Facilitation

Participants will undergo 8 weeks of supervised treatment, 3 sessions per week (24 sessions). Each session includes a warm-up with stretches, range-of-motion exercises, and Functional Strength Training (mini hops, stair climbing, ramp walking, sit-to-stand). Kinesio Taping will be applied from the foot's dorsum along the tibialis anterior and peroneus longus with 25-50% stretch for ankle support and dorsiflexor facilitation, re-applied every 3-4 days. In addition, Proprioceptive Neuromuscular Facilitation (PNF) lower-limb D1 flexion/extension patterns with manual resistance will be performed in 3 sets of 5 repetitions, lasting 35-40 minutes per session.

BEHAVIORALFunctional Strength Training and Kinesio Taping

Participants will undergo 8 weeks of supervised treatment, 3 sessions per week (24 sessions). Each session includes a warm-up with stretches, range-of-motion exercises, and Functional Strength Training (mini hops, stair climbing, ramp walking, sit-to-stand). Kinesio Taping will be applied from the foot's dorsum along the tibialis anterior and peroneus longus with 25-50% stretch for ankle support and dorsiflexor facilitation, re-applied every 3-4 days. No PNF techniques will be applied.

Sponsors

University of Lahore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* • Adults (18-35 years old) are diagnosed with fibular neuropathy due to trauma or compression. * Patients with muscle weakness, impaired balance and abnormal gait. * Both Male and female participants will be included. * Patients who test positive to the drag or slap test will be considered positive if the patient have difficulty in lifting the forefoot while walking, leading to dragging of the toes or compensatory hip/knee movements.

Exclusion criteria

* • Recent foot or ankle surgery (\<6 months). * Complete loss of nerve supply * Severe musculoskeletal or neurological conditions (Amyotrophic lateral sclerosis, multiple sclerosis, myopathies, severe osteoarthritis, severe compression, progressive neuropathies, severe balance and fall risk, Guillain-Barré Syndrome (GBS) and peripheral vascular diseases). * Allergies to Kinesio tape materials. * Patients who are not psychologically fit such as those who have undergone trauma and patients with severe psychological disorders (major depressive disorder, PTSD, schizophrenia) will be excluded if they have had a diagnosis within the last 6 months.

Design outcomes

Primary

MeasureTime frame
Change in dorsiflexor muscle strength measured by Manual Muscle Grading (MMG)Baseline (Week 0), Mid-point (Week 4), and Post-intervention (Week 8)

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026